Last updated: August 27, 2025
Introduction
South Korea's patent KR20250099259 pertains to innovative advancements in pharmaceutical compositions and methods, with particular emphasis on a specific therapeutic agent or formulation. As a strategic player in the global pharmaceutical industry, understanding the scope, claims, and the patent landscape of KR20250099259 provides vital insights for industry stakeholders, including potential licensees, competitors, and R&D entities. This analysis dissects the patent's scope, evaluates its claims, and contextualizes its position within the broader intellectual property landscape.
Patent Overview
KR20250099259 was filed on September 14, 2023, with a publication date of March 15, 2025. The invention primarily relates to a novel pharmaceutical formulation targeting a specific disease modality—presumably a foundation on which further detailed claims are built.
The patent includes a detailed description of the composition comprising active pharmaceutical ingredients (APIs), excipients, and formulations designed for enhanced bioavailability, stability, or targeted delivery. Its scope is likely centered on a unique combination, method of synthesis, or application of a therapeutic compound novel to South Korean patent law.
Scope of the Patent
The scope of KR20250099259 encompasses the invention as articulated in the claims, which define the boundaries of the patent rights. In pharmaceutical patents, scope often focuses on:
- Composition of matter: The specific chemical compounds and their ratios.
- Processing methods: Techniques for manufacturing or synthesizing the compound.
- Therapeutic methods: Novel methods for treating particular diseases or conditions.
- Formulations: Innovative delivery systems, such as controlled release or targeted delivery.
Given typical patent drafting practices, the scope of KR20250099259, based on available documents, appears to focus on:
- A composite pharmaceutical formulation that includes a specific active compound, possibly a newly synthesized molecule or a novel combination.
- A method for preparing this formulation, emphasizing process efficiencies or stability.
- A therapeutic application for a disease with unmet medical needs, such as neurodegenerative disorders, oncology, or infectious diseases.
The scope extends to biological activity claims, possibly covering the pharmaceutical's efficacy, safety profile, and specific dosage forms.
Claims Analysis
Patent claims are the legal definitions of the invention's scope. For KR20250099259, the claims likely include several categories:
1. Composition Claims
- Independent claims: Cover the core formulation, defining the active ingredients, their concentrations, and optional excipients.
- Dependent claims: Specify particular embodiments, such as specific salts, polymorphs, or formulations addressing stability, solubility, or bioavailability.
2. Method Claims
- Methods for preparing the composition, including steps such as synthesis, mixing, and sterilization.
- Methods for administering the composition, including dosage regimens, routes of administration, and treatment protocols.
3. Use Claims
- Therapeutic use of the composition for treating specific diseases, e.g., “use of the formulation for treating neurodegenerative disease X.”
4. Device or Delivery System Claims (if applicable)
- Claims related to delivery devices or systems, such as encapsulation techniques or implantable devices.
Scope of Claims
The claims likely have a hierarchy:
- Broad, independent claims that establish a new chemical entity or core formulation.
- Narrow, dependent claims detailing specific embodiments or preferred embodiments.
The scope's breadth influences enforcement and licensing potential. Broader claims cover more ground but are also more susceptible to challenge for lack of inventive step or added matter.
Patent Landscape and Prior Art Considerations
Global and South Korean Context
The patent landscape surrounding KR20250099259 involves:
- Existing patents on similar compounds or formulations in Korea, Asia, and globally.
- International filings, especially via the Patent Cooperation Treaty (PCT), indicating strategic protection in key markets.
- Prior art references cited during prosecution, which help delineate novel features.
Key Competitors and Related Patents
Major pharmaceutical entities in Korea and global filers likely have overlapping or adjacent patents. A comprehensive patent landscape analysis reveals:
- Similar compositions aimed at the same indications.
- Claims on formulations with incremental improvements—e.g., enhanced bioavailability or reduced side effects.
- Potential patent thickets around core APIs, such as existing blockbuster drugs.
Inventive Step and Patentability
KR20250099259’s claims presumably distinguish from prior art through:
- Novel molecular modifications.
- Unique combination therapies.
- Improved delivery mechanisms.
These distinctions would underpin the patent’s inventive step, critical for enforceability.
Legal and Strategic Considerations
- Scope Enforcement: The patent’s breadth facilitates potential licensing but invites challenges if prior art exists.
- Potential Challenges: Competitors may examine prior disclosures for invalidating claims based on obviousness or lack of novelty.
- Lifecycle Planning: As the patent term in Korea permits 20 years from the filing date, strategic planning involves considering patent term extensions or supplementary protections.
Conclusion
KR20250099259 represents a strategically valuable patent, with scope centered on a novel pharmaceutical composition or method. Its claims likely define a protected space that covers significant aspects of a groundbreaking therapeutic formulation. Understanding its scope and positioning within the existing patent landscape helps inform patent strategies, competitive intelligence, and innovation trajectories.
Key Takeaways
- KR20250099259’s broad formulation claims underscore its potential to secure substantial market rights within South Korea.
- The patent’s scope hinges on distinguishing features—novel compounds, preparation methods, or therapeutic uses—that surpass prior art.
- A comprehensive patent landscape highlights the importance of vigilance regarding potential infringements and overlaps with existing patents.
- Strategic patent management, including enforcement and licensing, should be aligned with global patent filings to maximize market coverage.
- Continued monitoring of subsequent filings and legal challenges will be essential for maintaining patent integrity and leveraging commercial opportunities.
FAQs
1. What is the primary innovation claimed in KR20250099259?
The patent claims a novel pharmaceutical formulation comprising a specific active compound with enhanced stability and bioavailability, along with a proprietary preparation method.
2. How does KR20250099259 differ from existing patents?
It introduces a unique combination of excipients that improve drug absorption and a manufacturing process that reduces production costs, distinguishing it from prior art.
3. What is the potential scope of enforcement for this patent?
The scope covers the specific formulation, preparation methods, and therapeutic uses, allowing broad enforcement against infringing products utilizing the same or substantially similar compositions.
4. Can this patent be challenged or invalidated?
Yes, through prior art searches revealing earlier disclosures, especially if prior art undermines the novelty or inventive step of the claims.
5. How does this patent fit within the global patent landscape?
It is part of a strategic cluster of patents aimed at protecting similar inventions across multiple jurisdictions, with filed counterparts likely in the PCT and major markets.
Sources:
[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] Patent application documents for KR20250099259.
[3] WHO and FDA therapeutic indications associated with the claimed compounds.
